JY
ANIX icon

Jeff Yass’s Anixa Biosciences ANIX Stock Holding History

Jeff Yass’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-99,468
Closed -$277K – 13328
2026
Q1 		$257K Sell
99,468
-152,606
-61% -$452K ﹤0.01% 11211
2025
Q4 		$786K Buy
252,074
+171,687
+214% +$703K ﹤0.01% 7728
2025
Q3 		$265K Buy
80,387
+63,584
+378% +$201K ﹤0.01% 10402
2025
Q2 		$55.5K Sell
16,803
-178,368
-91% -$510K ﹤0.01% 12080
2025
Q1 		$558K Sell
195,171
-86,522
-31% -$247K ﹤0.01% 8657
2024
Q4 		$654K Buy
281,693
+185,345
+192% +$576K ﹤0.01% 8011
2024
Q3 		$303K Sell
96,348
-16,045
-14% -$49.3K ﹤0.01% 9577
2024
Q2 		$248K Sell
112,393
-228,558
-67% -$648K ﹤0.01% 9870
2024
Q1 		$1.06M Buy
340,951
+267,648
+365% +$1.07M ﹤0.01% 6740
2023
Q4 		$284K Buy
73,303
+36,645
+100% +$124K ﹤0.01% 9943
2023
Q3 		$120K Sell
36,658
-10,600
-22% -$37.1K ﹤0.01% 10772
2023
Q2 		$151K Sell
47,258
-108,526
-70% -$418K ﹤0.01% 10566
2023
Q1 		$670K Buy
155,784
+84,761
+119% +$371K ﹤0.01% 7833
2022
Q4 		$302K Buy
71,023
+31,115
+78% +$150K ﹤0.01% 9078
2022
Q3 		$196K Buy
39,908
+22,119
+124% +$89.6K ﹤0.01% 10868
2022
Q2 		$54K Buy
+17,789
New +$56.1K ﹤0.01% 11933
2022
Q1 		– Sell
-19,300
Closed -$56.6K – 12917
2021
Q4 		$57K Sell
19,300
-26,606
-58% -$108K ﹤0.01% 12475
2021
Q3 		$219K Buy
45,906
+29,000
+172% +$131K ﹤0.01% 11287
2021
Q2 		$66K Buy
+16,906
New +$72K ﹤0.01% 12235
2015
Q4 		– Sell
-11,103
Closed -$53K – 9369
2015
Q3 		$53K Buy
+11,103
New +$51.6K ﹤0.01% 9349

Other funds holding ANIX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Jeff Yass's ANIX Position: Q2 2026 in Review

Jeff Yass sold out of Anixa Biosciences (ANIX) in Q2 2026, closing a stake of 99,468 shares — an estimated $277K sold.

Jeff Yass first reported a position in ANIX in Q3 2015 and held it in 20 quarters. The position peaked at $1.06M in Q1 2024. 62 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

  • Jeff Yass reported no remaining Anixa Biosciences position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 99,468 Anixa Biosciences shares in Q2 2026, an estimated $277K.
  • Jeff Yass first reported a position in Anixa Biosciences in Q3 2015 and held it in 20 quarters.
  • Jeff Yass's Anixa Biosciences position peaked at $1.06M in Q1 2024.
  • 62 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.